BLOG

Wednesday, October 31, 2018

Flexible, stable and potent against cancer

Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects -- especially when treating tumors. Scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor. Changing the linker between the two components allows for tuning the activity of this cytostatic drug, which is effective against a broad palette of cancers.

from Top Health News -- ScienceDaily https://ift.tt/2yHugYJ

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...